Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,023 Cr
up ₹101 Cr vs Nov 2023
- Stocks held
- 26
- unchanged
- Top 10 weight
- 69.7%
- of the portfolio in its ten largest
- Cash & debt
- 0.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 8
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In December 2023 it disclosed 26 stocks worth ₹2,023 Cr, up ₹101 Cr from Nov 2023. Its largest positions were Sun Pharmaceutical Industries Limited (12.7%), Suven Pharmaceuticals Limited (9.0%), IPCA Laboratories Limited (8.4%); the ten largest together made up 69.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.8% of its equity. Cash and debt stood at 0.9%. Compared with Nov 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
12%
Holds more cash than 12% of peers
Holdings in December 2023
Download CSVEvery line the fund disclosed, with the change against Nov 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.69%
- Δ weight
- down 0.31 pts
- Value
- ₹257 Cr
- Δ value
- up ₹6.8 Cr
- Status
- Added
- Weight
- 8.97%
- Δ weight
- up 0.35 pts
- Value
- ₹181 Cr
- Δ value
- up ₹15.8 Cr
- Status
- Added
- Weight
- 8.40%
- Δ weight
- down 0.60 pts
- Value
- ₹170 Cr
- Δ value
- down ₹3 Cr
- Status
- Trimmed
- Weight
- 7.91%
- Δ weight
- down 0.19 pts
- Value
- ₹160 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 7.14%
- Δ weight
- down 0.13 pts
- Value
- ₹145 Cr
- Δ value
- up ₹4.6 Cr
- Status
- Added
- Weight
- 5.25%
- Δ weight
- down 0.10 pts
- Value
- ₹106 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 5.07%
- Δ weight
- down 0.15 pts
- Value
- ₹103 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 4.86%
- Δ weight
- up 1.51 pts
- Value
- ₹98.3 Cr
- Δ value
- up ₹33.9 Cr
- Status
- Added
- Weight
- 4.83%
- Δ weight
- up 0.22 pts
- Value
- ₹97.6 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Weight
- 4.54%
- Δ weight
- up 0.20 pts
- Value
- ₹91.9 Cr
- Δ value
- up ₹8.4 Cr
- Status
- Added
- Weight
- 3.88%
- Δ weight
- down 0.35 pts
- Value
- ₹78.5 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 3.40%
- Δ weight
- up 0.02 pts
- Value
- ₹68.9 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 2.82%
- Δ weight
- up 0.07 pts
- Value
- ₹57 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Weight
- 2.71%
- Δ weight
- up 0.24 pts
- Value
- ₹54.9 Cr
- Δ value
- up ₹7.3 Cr
- Status
- Added
- Weight
- 2.60%
- Δ weight
- up 0.07 pts
- Value
- ₹52.6 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 1.78%
- Δ weight
- down 0.09 pts
- Value
- ₹36.1 Cr
- Δ value
- up ₹11 L
- Status
- Held
- Weight
- 1.76%
- Δ weight
- down 0.18 pts
- Value
- ₹35.7 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 1.69%
- Δ weight
- down 0.16 pts
- Value
- ₹34.3 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 1.54%
- Δ weight
- up 0.14 pts
- Value
- ₹31.1 Cr
- Δ value
- up ₹4.2 Cr
- Status
- Added
- Weight
- 1.48%
- Δ weight
- down 0.09 pts
- Value
- ₹29.9 Cr
- Δ value
- down ₹28 L
- Status
- Trimmed
- Weight
- 1.43%
- Δ weight
- up <0.01 pts
- Value
- ₹28.9 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 1.23%
- Δ weight
- up 0.33 pts
- Value
- ₹24.9 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 1.17%
- Δ weight
- up 0.80 pts
- Value
- ₹23.6 Cr
- Δ value
- up ₹16.5 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.86%
- Δ weight
- down 1.44 pts
- Value
- ₹17.3 Cr
- Δ value
- down ₹26.9 Cr
- Status
- Trimmed
- Weight
- 0.71%
- Δ weight
- down 0.08 pts
- Value
- ₹14.4 Cr
- Δ value
- down ₹89 L
- Status
- Trimmed
- Weight
- 0.52%
- Δ weight
- down 0.04 pts
- Value
- ₹10.5 Cr
- Δ value
- down ₹22 L
- Status
- Trimmed
- Weight
- 0.44%
- Δ weight
- down 0.03 pts
- Value
- ₹8.9 Cr
- Δ value
- down ₹9 L
- Status
- Trimmed
- Weight
- 0.32%
- Δ weight
- down <0.01 pts
- Value
- ₹6.5 Cr
- Δ value
- up ₹28 L
- Status
- Added
What changed, Nov 2023 to Dec 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Globus Medical Incup ₹33.9 Cr (+1.51% pts)
- Illumina Incup ₹16.5 Cr (+0.80% pts)
- Suven Pharmaceuticals Limitedup ₹15.8 Cr (+0.35% pts)
- Alkem Laboratories Limitedup ₹9 Cr (+0.22% pts)
- Concord Biotech Limitedup ₹8.4 Cr (+0.20% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2023, the weight rose most in Healthcare Equipment & Supplies (+1.5 pts) and Healthcare Services (+0.4 pts), and fell most in Pharmaceuticals & Biotechnology (−1.7 pts) and Insurance (−0.2 pts).
- Healthcare Equipment & Supplies6.1% → 7.6%+1.5 pts
- Healthcare Services12.0% → 12.4%+0.4 pts
- Pharmaceuticals & Biotechnology73.5% → 71.8%−1.7 pts
- Insurance1.9% → 1.7%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2020 | Dec 2022 | Jun 2023 | Sep 2023 | Nov 2023 | Dec 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.8% | 63.9% | 71.1% | 73.1% | 73.5% | 71.8% |
| Healthcare Services | 20.4% | 18.9% | 13.6% | 11.7% | 12.0% | 12.4% |
| Healthcare Equipment & Supplies | 3.6% | 7.1% | 6.4% | 6.9% | 6.1% | 7.6% |
| Pharmaceuticals | 6.6% | 6.4% | 5.4% | 5.5% | 5.7% | 5.7% |
| Insurance | 3.6% | 2.6% | 2.4% | 1.9% | 1.9% | 1.7% |
| Retailing | — | 1.0% | 1.1% | 0.9% | 0.8% | 0.7% |
Allocation in Dec 2023change vs Nov 2023
- Pharmaceuticals & Biotechnology (14)71.8%▼ 1.7 pts
- Healthcare Services (5)12.4%▲ 0.4 pts
- Healthcare Equipment & Supplies (2)7.6%▲ 1.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2023
0.9%
▼ 1.4 pts vs Nov 2023
- Cash alone
- 0.9%
- cash and net receivables
- A year earlier
- 4.2%
- Dec 2022 · now ▼ 3.4 pts
- Last 12 months
- <0.1% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.